Literature DB >> 21228352

Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes.

Li-Min Li1, Dong-Xia Hou, Ya-Lan Guo, Jun-Wei Yang, Yuan Liu, Chen-Yu Zhang, Ke Zen.   

Abstract

Advanced glycation end products (AGEs) delay spontaneous apoptosis of monocytes and contribute to the development of inflammatory responses. However, the mechanism by which AGEs affect monocyte apoptosis is unclear. We studied the role of microRNA-214 (miR-214) and its target gene in AGE-induced monocytic apoptosis delay. Using microRNA (miRNA) microarray and stem-loop, quantitative RT-PCR assay, we studied genome-wide miRNA expression in THP-1 cells treated with or without AGEs. Significant upregulation of miR-214 was consistently observed in THP-1 and human monocytes treated with various AGEs, and AGE-induced monocytic miR-214 upregulation was likely through activation of receptor for AGEs. A striking increase in miR-214 was also detected in monocytes from patients with chronic renal failure. Luciferase reporter assay showed that miR-214 specifically binds to the phosphatase and tensin homolog (PTEN) mRNA 3'-untranslated region, implicating PTEN as a target gene of miR-214. PTEN expression is inversely correlated with miR-214 level in monocytes. Compared with normal monocytes, AGE-treated monocytes and monocytes from chronic renal failure patients exhibited lower PTEN levels and delayed apoptosis. Overexpression of pre-miR-214 led to impaired PTEN expression and delayed apoptosis of THP-1 cells, whereas knockdown of miR-214 level largely abolished AGE-induced cell survival. Our findings define a new role for miR-214-targeting PTEN in AGE-induced monocyte survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228352     DOI: 10.4049/jimmunol.1001633

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 2.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

3.  MiR-92a regulates viability and angiogenesis of endothelial cells under oxidative stress.

Authors:  Lan Zhang; Mi Zhou; Gangjian Qin; Neal L Weintraub; Yaoliang Tang
Journal:  Biochem Biophys Res Commun       Date:  2014-03-17       Impact factor: 3.575

4.  MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1.

Authors:  Xin Dai; Xi Chen; Qun Chen; Lei Shi; Hongwei Liang; Zhen Zhou; Qian Liu; Wenjing Pang; Dongxia Hou; Cheng Wang; Ke Zen; Yaozong Yuan; Chen-Yu Zhang; Lu Xia
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

5.  MicroRNA expression profiling of human blood monocyte subsets highlights functional differences.

Authors:  Truong-Minh Dang; Wing-Cheong Wong; Siew-Min Ong; Peng Li; Josephine Lum; Jinmiao Chen; Michael Poidinger; Francesca Zolezzi; Siew-Cheng Wong
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

6.  miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.

Authors:  Chenyang Zhao; Weijia Sun; Pengfei Zhang; Shukuan Ling; Yuheng Li; Dingsheng Zhao; Jiang Peng; Aiyuan Wang; Qi Li; Jinping Song; Cheng Wang; Xiaolong Xu; Zi Xu; Guohui Zhong; Bingxing Han; Yan-Zhong Chang; Yingxian Li
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 7.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

8.  miR-21 and miR-214 are consistently modulated during renal injury in rodent models.

Authors:  Laura Denby; Vasudev Ramdas; Martin W McBride; Joe Wang; Hollie Robinson; John McClure; Wendy Crawford; Ruifang Lu; Dianne Z Hillyard; Raya Khanin; Reuven Agami; Anna F Dominiczak; Claire C Sharpe; Andrew H Baker
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

9.  IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.

Authors:  Aimalie L Hardaway; Izabela Podgorski
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

10.  MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy.

Authors:  Zhenyou Zou; Linping Wu; Hanying Ding; Yang Wang; Yaqin Zhang; Xuejiao Chen; Xi Chen; Chen-Yu Zhang; Qipeng Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.